Clinical Study
Therapeutic Role of Mobilized Bone Marrow Cells in Children with Nonischemic Dilated Cardiomyopathy
Table 2
Comparison between New York Heart Association class of group 1 patients before and after GCSF treatment.
| | New York Heart Association classification before treatment | | After treatment | I | II | III-IV | value | | Number = 2 (10%) | Number = 12 (60%) | Number = 6 (30%) | |
| I | 2 (100) | 11 (91.7) | 2 (33.3) | | II | 0 | 1 (8.3) | 2 (33.3) | 0.002 | III-IV | 0 | 0 | 2 (33.3) | |
|
|